$37.02
0[0.00%]
Last update: 4:03PM Get Real Time Here
Celldex Therapeutics
(NASDAQ:CLDX)Celldex Therapeutics Stock (NASDAQ:CLDX), Earnings Estimates, EPS, and Revenue
Celldex Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-0.730
Quarterly Revenue Estimate
$920K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$6.9M
Analyze the earnings history of Celldex Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/06/2024 | PM | CLDX | Q1 | -$0.62 | -$0.73 | — | — | $967.00K | $920.00K | — | — | Get Alert |
| 02/26/2024 | AM | CLDX | Q4 | -$0.56 | -$0.74 | -$0.83 | -12.16% | $1.61M | $840.00K | $4.13M | 391.90% | Get Alert |
| 11/02/2023 | PM | CLDX | Q3 | -$0.57 | -$0.68 | -$0.81 | -19.12% | $407.00K | $580.00K | $1.52M | 161.55% | Get Alert |
| 08/08/2023 | PM | CLDX | Q2 | -$0.77 | -$0.67 | -$0.65 | 2.99% | $163.00K | $530.00K | $268.00K | -49.43% | Get Alert |
| 05/04/2023 | PM | CLDX | Q1 | -$0.49 | -$0.63 | -$0.62 | 1.59% | $174.00K | $410.00K | $967.00K | 135.85% | Get Alert |
| 02/28/2023 | PM | CLDX | Q4 | -$0.43 | -$0.59 | -$0.56 | 5.08% | $333.00K | $260.00K | $1.61M | 520.38% | Get Alert |
| 11/09/2022 | PM | CLDX | Q3 | -$0.37 | -$0.58 | -$0.57 | 1.72% | $153.00K | — | $407.00K | — | Get Alert |
| 08/08/2022 | PM | CLDX | Q2 | -$0.34 | -$0.51 | -$0.77 | -50.98% | $3.48M | $400.00K | $163.00K | -59.25% | Get Alert |
| 05/05/2022 | PM | CLDX | Q1 | -$0.42 | -$0.45 | -$0.49 | -8.89% | $685.00K | $560.00K | $174.00K | -68.93% | Get Alert |
| 02/28/2022 | PM | CLDX | Q4 | -$0.55 | -$0.42 | -$0.43 | -2.38% | $3.79M | — | $333.00K | — | Get Alert |
| 11/09/2021 | PM | CLDX | Q3 | -$0.36 | -$0.37 | -$0.37 | 0.00% | $668.00K | $1.12M | $153.00K | -86.34% | Get Alert |
| 08/05/2021 | PM | CLDX | Q2 | -$0.50 | — | -$0.34 | — | $236.00K | $685.00K | $3.48M | 408.03% | Get Alert |
| 05/06/2021 | PM | CLDX | Q1 | -$0.73 | -$0.38 | -$0.42 | -10.53% | $2.73M | $685.00K | $685.00K | 0.00% | Get Alert |
| 03/29/2021 | PM | CLDX | Q4 | -$0.64 | — | -$0.55 | — | $887.00K | — | $3.79M | — | Get Alert |
| 11/05/2020 | PM | CLDX | Q3 | -$0.75 | — | -$0.36 | — | $546.00K | — | $668.00K | — | Get Alert |
| 08/06/2020 | PM | CLDX | Q2 | -$0.84 | -$0.58 | -$0.50 | 13.79% | $715.00K | $800.00K | $236.00K | -70.50% | Get Alert |
| 05/06/2020 | PM | CLDX | Q1 | -$1.40 | — | -$0.73 | — | $1.43M | — | $2.73M | — | Get Alert |
| 03/26/2020 | PM | CLDX | Q4 | -$0.81 | -$0.90 | -$0.64 | 28.89% | $1.76M | $810.00K | $887.00K | 9.51% | Get Alert |
| 11/12/2019 | PM | CLDX | Q3 | -$0.60 | -$0.84 | -$0.75 | 10.71% | $941.00K | $1.26M | $546.00K | -56.67% | Get Alert |
FAQ
When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?
Celldex Therapeutics (CLDX) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on February 26, 2024 for Q4.
What were the latest earnings per share (EPS) for Celldex Therapeutics (NASDAQ:CLDX)?
The Actual EPS was $-0.83, which missed the estimate of $-0.74.
What were Celldex Therapeutics’s (NASDAQ:CLDX) revenues?
The Actual Revenue was $4.1M, which beat the estimate of $840K.
Browse earnings estimates, EPS, and revenue on all stocks.